Active Projects By David Sumrall

Search
Close this search box.
CDC Announces Potential ‘Safety Concern’ Related to Pfizer COVID-19 Vaccine

CDC Announces Potential ‘Safety Concern’ Related to Pfizer COVID-19 Vaccine

The CDC is warning that there could be a connection between Pfizer vaccines and strokes among people over 65.

The CDC is finally admitting what everyone except Democrats has known to be true for a while. The experimental vaccines could be killing people. They are saying that Pfizer’s COVID-19 vaccines could be linked to strokes. Just think about all of the stories that have been published about athletes falling over dead unexpectedly. The courts could be sorting this out for years. Lawsuits for wrongful death could be filed against companies that forced their employees to be vaccinated or lose their jobs.

The big drug companies will be covered unless it is proven that they sold the vaccines despite knowing they could be deadly and that would be difficult to prove in court unless a whistleblower comes forth with reports that the company had. But, employers would be open to charges of coercion of their employees by threatening to fire them if they did not get the jab.

The FDA will have to answer for approving these vaccines, which have never been proven to be safe or effective. But, it is unlikely that anyone will get punished over it. However, they will no longer have any credibility with anyone except Democratic voters who reject facts that go against their ideology.

The CDC put out an advisory that people who are 65 years old or older are at risk for strokes after the injection of the vaccines:

“Following the availability and use of the updated (bivalent) COVID-19 vaccines, CDC’s Vaccine Safety Datalink (VSD), a near real-time surveillance system, met the statistical criteria to prompt additional investigation into whether there was a safety concern for ischemic stroke in people ages 65 and older who received the Pfizer-BioNTech COVID-19 Vaccine, Bivalent. Rapid-response investigation of the signal in the VSD raised a question of whether people 65 and older who have received the Pfizer-BioNTech COVID-19 Vaccine, Bivalent were more likely to have an ischemic stroke in the 21 days following vaccination compared with days 22-44 following vaccination.”

“This preliminary signal has not been identified with the Moderna COVID-19 Vaccine, Bivalent. There also may be other confounding factors contributing to the signal identified in the VSD that merit further investigation. Furthermore, it is important to note that, to date, no other safety systems have shown a similar signal and multiple subsequent analyses have not validated this signal. Although the totality of the data currently suggests that it is very unlikely that the signal in VSD represents a true clinical risk, we believe it is important to share this information with the public,” the press release states. “CDC and FDA will continue to evaluate additional data from these and other vaccine safety systems.”

The press release listed various other considerations which did not indicate an elevated ischemic stroke risk related to the vaccine:

“A large study of updated (bivalent) vaccines (from Pfizer-BioNTech and Moderna) using the Centers for Medicare and Medicaid Services database revealed no increased risk of ischemic stroke. A preliminary study using the Veterans Affairs database did not indicate an increased risk of ischemic stroke following an updated (bivalent) vaccine.”

“The Vaccine Adverse Event Reporting System (VAERS) managed by CDC and FDA has not seen an increase in reporting of ischemic strokes following the updated (bivalent) vaccine. Pfizer-BioNTech’s global safety database has not indicated a signal for ischemic stroke with the updated (bivalent) vaccine.”

Pfizer put out a statement defending itself:

“Neither Pfizer and BioNTech nor the CDC or the U.S. Food and Drug Administration (FDA) have observed similar findings across numerous other monitoring systems in the U.S. and globally and there is no evidence to conclude that ischemic stroke is associated with the use of the companies’ COVID-19 vaccines. Compared to published incidence rates of ischemic stroke in this older population, the companies to date have observed a lower number of reported ischemic strokes following the vaccination with the Omicron BA.4/BA.5-adapted bivalent vaccine. The CDC continues to recommend vaccination with the Pfizer-BioNTech Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine for all authorized ages and indications.”

Share the Post: